Pipeline Lundbeck to present new Vyepti and bocunebart data at EAN 2026 PharmaTimesLundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27-30 June in Geneva.NeuroscienceRead full story pharminent June 24, 2026 (Last updated: June 24, 2026) PharmaTimes Lundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27-30 June in Geneva. Neuroscience Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Boehringer and Combotope partner for cancer antibodiesNext: Novartis Strikes Up-to-$1.9 Billion Oncology Discovery Collaboration With Antares Therapeutics Related Stories Pipeline New biotech cAMPfield emerges with $180M to reshape IBD treatment pharminent June 18, 2026 Pipeline J&J adds rare disease wAIHA to Imaavy’s potential uses pharminent June 11, 2026 Pipeline Novartis gets win for another Avidity muscular dystrophy AOC pharminent June 11, 2026
